PortfoliosStock ScreensStocksStockXcel

AVTX

AVTX | US

14.42

USD

1.07

8.01%

AVTX | US

About AVTX

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

16/04/2026

Close

14.42

Open

13.49

High

14.55

Low

13.44

Avalo Therapeutics Inc. a clinical stage biotechnology company focuses on the development of therapies for the treatment of immune dysregulation. The company's drug candidates include AVTX-002 a fully human anti-LIGHT monoclonal antibody which is under Phase II clinical trial for the treatment of non-eosinophilic asthma as well as Crohn's disease; Phase III clinical trial for the treatment of COVID-19 acute respiratory distress syndrome; and AVTX-008 a fully human B and T Lymphocyte Attenuator (BTLA) agonist fusion protein. It also develops AVTX-803 a L-fucose monosaccharide therapy for treatment of Leukocyte Adhesion Deficiency Type II. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics Inc. in August 2021. Avalo Therapeutics Inc. was incorporated in 2011 and is headquartered in Rockville Maryland.

View Less

AVTX | US

Risk
85.4
Sharpe
1.96
Luna's Score
45/100
Recommendation
Sell

Luna says (AVTX | US)

What's Working

Low Debt to Equity (< 0.25)

Value Stock (Price to Book < 3)

Strong Sharpe Ratio (> 1.2)

What's not Working

Price Below SMA10D

High Short-term Volatility

High 6-Month Volatility (>65%)

Microcap (<300M USD)

High Market Beta (> 0.8)

Weak Operating Margin (< 10%)

Declining Revenue (< 0%)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

10 days

92.9%

1 month

85.4%

3 months

77.4%

6 months

78.9%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

1.66

Debt to equity

-0.80

Debt to assets

0.02

Ent. to EBITDA

-0.19

Ent. to rev.

19.29

PEG

-

Other Fundamentals

EBITDA

-22.05M

MarketCap

139.87M

MarketCap(USD)

139.87M

Div. yield

-

Op. margin

-2.75K

Erngs. growth

-

Rev. growth

-36.30

Ret. on equity

-524.01

Short ratio

3.46

Short perc.

0.56

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Range10D

5.32

Range1M

5.39

Range3M

6.04

Volumes: Market Activity

Rel. volume

0.87

Price X volume

11.21M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
QSIQSIBiotechnology1.04148.06M-0.95%n/a0.71%
TransCode Therapeutics Inc. Common StockRNAZBiotechnology8.7146.76M-2.36%0.0017.19%
MOLECULAR PARTNERS AGMOLNBiotechnology4.18146.36M-0.48%n/a1.96%
Spero Therapeutics IncSPROBiotechnology2.68144.85M1.52%3.766.13%
Tiziana Life Sciences PLCTLSABiotechnology1.34136.03M0.75%n/a0.00%
Elicio Therapeutics Inc.ELTXBiotechnology12.6131.91M6.96%5.18-388.56%
Quanterix CorporationQTRXBiotechnology3.4130.49M-5.56%n/a11.75%
Seer Inc.SEERBiotechnology2.05125.93M4.59%n/a7.43%
Corbus Pharmaceuticals Holdings IncCRBPBiotechnology10.14122.13M1.40%n/a11.79%
Mawson Infrastructure Group Inc. Common StockMIGIBiotechnology6.16114.29M-1.75%n/a571.64%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Kewaunee Scientific CorporationKEQUBuilding Products & Equipment34.99100.48M0.63%5.1619.82%
Virco Mfg. CorporationVIRCBuilding Products & Equipment6.1299.69M0.49%9.0939.79%
Saga Communications IncSGABroadcasting - Radio11.9374.70M1.14%14.487.10%
ILAGILAGBuilding Products & Equipment3.3259.96M0.00%n/a5.48%
Beasley Broadcast Group IncBBGIBroadcasting - Radio1421.32M2.04%n/a204.46%
REE Automotive Ltd. Class A Ordinary SharesREERecreational Vehicles0.61211.83M-2.84%n/a58.43%
Antelope Enterprise Holdings LimitedAEHLBuilding Products & Equipment0.7410.81M6.52%0.0316.03%
EZGO Technologies Ltd. Ordinary SharesEZGORecreational Vehicles1.3353.41M-2.06%n/a17.32%
Twin Vee PowerCats Co. Common StockVEEERecreational Vehicles0.21672.06M-6.19%n/a19.98%
Vision Marine Technologies IncVMARRecreational Vehicles1.44793.44K-17.24%n/a0.00%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA-0.19-Cheaper
Ent. to Revenue19.29-Cheaper
PE Ratio-41.03-
Price to Book1.6615.55Cheaper
Dividend Yield---
Std. Deviation (3M)77.39-Par
Debt to Equity-0.80-1.23Expensive
Debt to Assets0.020.25Cheaper
Market Cap139.87M-Emerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007